TrialJournal of neuro-oncology2026

Therapeutic effects of selumetinib on diffuse neurofibroma and optic pathway glioma in neurofibromatosis type 1.

Soojin Hwang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.